Kinney Horn

Company: Immunome Inc.

Job title: CBO

Bio:

Kinney has over twenty years of experience in life science finance, leadership, operations, and biopharmaceutical Business Development roles, representing over $30B in transactions. Prior to joining Immunome, Kinney was Chief Business Officer of Olema Oncology, where he was part of the team that completed the company’s $85M Series C crossover financing round and $240M IPO. Before Olema, he was an Entrepreneur in Residence at EcoR1 Capital.

Seminars:

Opportunity to be First-in-Class: Considerations for Collaborations with New Targets 11:10 am

What are the economics of having a new target for others to develop an ADC around? Discussing opportunities to be first-in-class pursuing underexploited targets  Debating the decision to leverage the best linker-payload platform or off-patent technologies, considering the influence on the side effect profileRead more

day: Conference Day Two